Results 121 to 130 of about 3,248 (232)

Recent advances, challenges and updates on the development of therapeutics for malaria

open access: yesEXCLI Journal : Experimental and Clinical Sciences
Malaria has developed as a serious worldwide health issue as a result of the introduction of resistant Plasmodium species strains. Because of the common chemo resistance to most of the existing drugs on the market, it poses a severe health problem and ...
Rimmy Nandal   +10 more
doaj   +1 more source

Epidemiología y tratamiento de Plasmodium vivax = The epidemiology and treatment of Plasmodium vivax [PDF]

open access: yes, 2014
[spa] La carga de enfermedad y las muertes relacionadas con la malaria han disminuido a nivel global, principalmente gracias a las mejoras en la implementación de las intervenciones para prevenir y tratar la malaria, y en particular al uso de las ...
Betuela, Inoni
core   +1 more source

Epidemiologie und Behandlung der importierten Malaria tropica [PDF]

open access: yes, 2018
An der Malaria erkranken weltweit ca. 212 Millionen Menschen pro Jahr und ca. 430.000 Todesfälle an Malaria werden pro Jahr registriert. Die Malaria tropica wird durch Reisende und Migranten jedoch auch häufig nach Europa importiert.
Zoller, Thomas
core   +1 more source

Response to comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis'

open access: yeseLife
In our recent paper on the clinical pharmacology of tafenoquine (Watson et al., 2022), we used all available individual patient pharmacometric data from the tafenoquine pre-registration clinical efficacy trials to characterise the determinants of anti ...
James A Watson   +12 more
doaj   +1 more source

The challenges of malaria elimination in the Asia–Pacific region

open access: yes
Medical Journal of Australia, Volume 221, Issue 4, Page 182-185, August 2024.
Freya JI Fowkes   +5 more
wiley   +1 more source

Comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis'

open access: yeseLife
A single 300 mg dose of tafenoquine, in combination with chloroquine, is currently approved in several countries for the radical cure (prevention of relapse) of Plasmodium vivax malaria in patients aged ≥16 years.
Raman Sharma   +10 more
doaj   +1 more source

Development of the Stem of Jatropha Multifida Linn as a New Antimalarial Through Erythrocytes Test on Mus Musculus Infected by Plasmodium Berghei [PDF]

open access: yes, 1991
Introduction : Jatropha multifida Linne is known as Betadin plant by the Bengkulunese. The stem extract of J. multifida has antibacterial activity. This study examined the potential of stem extract of J.
Sundaryono, A. (Agus)   +2 more
core   +1 more source

Author response: The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis

open access: gold, 2022
James A Watson   +12 more
openalex   +1 more source

Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient data. [PDF]

open access: yes, 2015
BACKGROUND: Artemisinin-resistant Plasmodium falciparum has emerged in the Greater Mekong sub-region and poses a major global public health threat. Slow parasite clearance is a key clinical manifestation of reduced susceptibility to artemisinin.
d'Alessandro, Umberto   +9 more
core   +1 more source

Discovery of a quinoline-4-carboxamide derivative with a novel mechanism of action, multistage antimalarial activity, and potent in vivo efficacy [PDF]

open access: yes, 2016
The antiplasmodial activity, DMPK properties, and efficacy of a series of quinoline-4-carboxamides are described. This series was identified from a phenotypic screen against the blood stage of Plasmodium falciparum (3D7) and displayed moderate potency ...
Achim Porzelle   +27 more
core   +7 more sources

Home - About - Disclaimer - Privacy